---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-035727"
form_type: "8-K"
ticker: "CSBR"
cik: "0000771856"
company_name: "CHAMPIONS ONCOLOGY, INC."
filed_at: "2025-07-23T23:59:59+00:00"
generated_at: "2026-05-18T03:53:16.341182+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Champions Oncology reports record annual revenue $57M (+14%), net income $4.6M for FY2025

## Summary
- Record annual revenue $57M, up 14% YoY; net income $4.6M vs loss of $7.4M prior year.
- Adjusted EBITDA income $7.1M (vs loss of $3.9M); year-end cash $9.8M with no debt.
- Q4 revenue $12.3M, down 12% YoY; Q4 adjusted EBITDA loss of $1.2M.
- Data license revenue contributed $4.7M for fiscal year; new high-margin data business launched.
- CEO cites return to growth and profitability; strong pipeline for FY2026.

## SEC filing metadata
- accession: 0001628280-25-035727
- form_type: 8-K
- ticker: CSBR
- cik: 0000771856
- company_name: CHAMPIONS ONCOLOGY, INC.
- filed_at: 2025-07-23T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/771856/000162828025035727/0001628280-25-035727-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/771856/000162828025035727/csbr-20250723.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-035727
- JSON: https://secwatch.observer/filing/0001628280-25-035727.json
- Plain text: https://secwatch.observer/filing/0001628280-25-035727.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.